Back
Coya Therapeutics, Inc. 10K Form
Sell
32
COYA
Coya Therapeutics, Inc.
Last Price:
$6.06
Seasonality Move:
29.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive COYA News And Ratings
See the #1 stock for the next 7 days that we like better than COYA
COYA Financial Statistics
Sales & Book Value
| Annual Sales: | $3.6M |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.63 |
| Price / Book: | 4.62 |
Profitability
| EPS (TTM): | -1.10230 |
|---|---|
| Net Income (TTM): | $-18.4M |
| Gross Margin: | $3.5M |
| Return on Equity: | -57.41% |
| Return on Assets: | -50.15% |
Coya Therapeutics, Inc. Earnings Forecast
Key Coya Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for COYA is 99.23%.
-
The Selling, General & Administrative Expenses for COYA have been equal to 250.02% of Gross Profit Margin.
-
The Research & Development expenses have been 333.86% of Revenue.
-
The Net Earning history of COYA is -418.69% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Coya Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | COYA |
| Website: | coyatherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.73 |
| Quick Ratio: | 7.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
COYA Technical Analysis vs Fundamental Analysis
Sell
32
Coya Therapeutics, Inc. (COYA)
is a Sell
Is Coya Therapeutics, Inc. a Buy or a Sell?
-
Coya Therapeutics, Inc. stock is rated a SellThe current Coya Therapeutics, Inc. [COYA] share price is $6.02. The Score for COYA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.